Outer membrane protein A (OmpA) is a porin involved in Acinetobacter baumannii pathogenesis. However, OmpA clinical implication in hospital-acquired infections remains unknown. We aimed to determine whether OmpA overproduction was a risk factor associated with pneumonia, bacteremia, and mortality.
formation [8] , and binding to factor H, which may allow A. baumannii to develop serum resistance [14] .
A. baumannii ventilator-associated pneumonia and bacteremia have been associated with crude mortality rates of 40% and 34%, respectively [15, 16] . Extrinsic and host risk factors associated with A. baumannii pneumonia and bacteremia are well established, including tracheostomy, previous antibiotic therapy, intensive care unit (ICU) stay, recent surgery, the presence of underlying disease, immunosuppressive treatment, respiratory failure at ICU admission, previous sepsis, and highly invasive procedures [17, 18] . However, the clinical impact of bacterial pathogenic features, such as the production of OmpA needs to be described. In the present study, we aimed to determine whether ompA overexpression and overproduction would be considered a risk factor for the development of A. baumannii pneumonia and bacteremia, and for the increased mortality rate, in 2 cohorts (multicenter and unicenter) of patients colonized or infected by A. baumannii.
MATERIALS AND METHODS

Clinical Cohorts
This is a post hoc analysis of patients from whom A. baumannii had been isolated from respiratory samples. Patients from 2 prospective observational cohorts of A. baumannii colonization or infection (see below) were eligible. Both studies had been approved by the pertinent ethics committee ( [19] . From the 246 patients, 446 A. baumannii isolates were recovered, which belonged to 68 clones differentiated by pulsed-field gel electrophoresis [19, 20] . The A. baumannii isolates used in this study were obtained from respiratory samples of patients with nosocomial pneumonia or lower respiratory tract colonization, who were selected according to algorithm shown in Figure 1 . Only the first isolate from each patient was studied. Nosocomial acquisition was defined according to conventional definitions from the Centers for Disease Control and Prevention [21] . For the current study, patients without previous bacterial isolates and a high bacterial count in respiratory samples were selected, as shown in Figure 1 . Five clones differentiated by pulsed-field gel electrophoresis had been recognized among the 29 isolates of A. baumannii collected. Only 1 isolate from each patient was studied; for the PP, the first isolate after the diagnosis was chosen.
Variables
The main dependent variables were death and the presence of A. baumannii pneumonia. Death was defined as any-cause death within the hospitalization time in the multicenter cohort and within the first 30 days after onset of A. baumannii pneumonia or colonization in the unicenter cohort. The classification of colonization or pneumonia was made by the clinicians in charge of the patients, using Centers for Disease Control and Prevention criteria [21] in the multicenter cohort and Clinical Pulmonary Infection Score (CPIS) criteria [22] in the unicenter cohort. Bacteremic pneumonia was defined by the presence of A. baumannii bloodstream infection associated with the pneumonia. Several independent demographic and clinical variables were analyzed: age; sex; comorbid conditions (Charlson score [23] , McCabe score [24] , and immunosuppressive treatment), surgery, ICU stay, mechanical ventilation, tracheostomy, and severe sepsis and septic shock [25] .
Molecular Studies
Quantitative Reverse-Transcription Polymerase Chain Reaction
The 72 clinical isolates of both cohorts were analyzed for the expression of the ompA gene. DNase-treated bacterial RNA was isolated following the protocol of Trizol Max Bacterial Enhancement Reagent kit (Trizol Max kit; Ambion) from cultures grown to an optical density of 0.6 in Luria-Bertani broth. Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) was performed with an MX3000P system (Stratagene), as described elsewhere [26] . The primers and TaqMan probes (Life Technology) were used as described elsewhere [26] 
Western Blot
The outer membrane fraction from ATCC 17978, 4 isolates each from CP and PP from the multicenter cohort with different ompA expression levels, were isolated as described elsewhere [27] . The OmpA expression level was analyzed following the protocol detailed in the Supplemental Materials.
In Vivo Studies
To study the role of OmpA in the virulence of A. baumannii, a murine peritoneal sepsis model was performed using an A. baumannii ATCC 17978 wild-type (wt) strain, its isogenic ompA knockout strain, JPAB01 [28] , and the ompA complemented JPAB01 strain, JPAB01+pJPAB01 [28] .
Peritoneal Sepsis Infection Survival Model
A murine model of peritoneal sepsis by A. baumannii was established by intraperitoneal inoculation of bacteria [11] . In brief, female mice C57BL/6 were inoculated with 0.5 mL of the bacterial suspension, obtained after growing for 20-24 hours in Luria Bertani broth (LB) at 37°C and mixed 1:1 with a saline solution of porcine mucin at 10% (wt/vol). Three groups of 6 mice C57BL/6 for each strain were inoculated with 8 decreased bacterial inocula from 8.5-2.2 log colony-forming units (CFUs)/mL of ATCC 17978 wt, JPAB01, or JPAB01+pJPAB01 strain [28, 29] , and deaths were recorded for 7 days. Median lethal dose (LD 50 ) values for the strains used in challenge studies were determined using the Probit method.
In Vivo Dissemination of A. baumannii
Three groups of 5 C57BL/6 mice were inoculated intraperitoneally with 5.3 log CFUs/mL of ATCC 17978 wt, JPAB01, or JPAB01+pJPAB01 strain. Spleens and lungs were aseptically extracted at 24 hours after inoculation. Tissue samples were homogenized in 2 mL of saline solution using the Stomacher 80 laboratory blender (Tekmar). To determine the bacterial load, serial dilutions 1:10 were plated on LB agar with no antibiotic or with either ticarcillin (80 µg/mL) or tetracycline (25 μg/mL).
Statistical Analysis
For animal model studies, Student t test was used to determine differences between means, and Kaplan-Meier test was performed to determine the difference between mortality rates. The Shapiro-Wilk test was used to test for normality.
Risk factors for PP were studied by comparing PP or bacteremic patients (BPP) with CP. Fisher and χ2 tests were used in the univariate analysis for categorical variables, and continuous variables were analyzed using 2-sample t test or MannWhitney U test, as appropriate. Logistic regression analysis was performed to identify independent risk factors for pneumonia, bacteremia, and death. Variables known to be associated with pneumonia, bacteremia, or death, or with P values ≤.10 in bivariate analysis, were included in the multivariate analysis. Furthermore, multivariate analysis of the variables associated with death, including OmpA production, was performed for CP and PP, and for PP of both cohorts. Differences were considered significant at P < .05. All statistical analyses were performed using SPSS software, version 16.0 (SPSS).
RESULTS
Death Induced by A. baumannii in Murine Peritoneal Sepsis Model
To evaluate the effect of OmpA in the A. baumannii virulence, a murine peritoneal sepsis model was carried out in 6 mice of each group. For the 3 strains used in this study, mortality rate was dependent on the concentration of bacteria in the inoculum (Supplementary Table S1 ). The 100% lethal dose, LD 50 , and LD 0 for the JPAB01 strain were greater than for ATCC 17978 wt strain (5.3, 4.75, and 4.3 vs 3.2, 2.7, and 2.2 log 10 CFUs/mL, respectively, with ratios of 1.65, 1.76, and 1.95, respectively). The LD 50 and LD 0 for the JPAB01+pJPAB01 strain (3.2 and 2.2 log 10 CFUs/mL, respectively) were lower than for the JPAB01 strain (4.75 and 4.3 log 10 CFUs/mL; Supplementary Table S1 ). Kaplan-Meier analysis revealed differences between animal groups receiving the same inoculum of JPAB01 and ATCC 17978 wt strains (P = .03, for approximately 5.3 log 10 CFUs/mL) (Fig. S1) . Moreover, ompA complementation in the mutant strain restored the virulence of A. baumannii (Fig. S1 ). These results demonstrate that OmpA plays an important role in the infective capacity and death caused by A. baumannii in vivo.
Dissemination of A. baumannii in Murine Peritoneal Sepsis Model
To compare the dissemination to different organs of the ATCC 17978 wt, JPAB01, and JPAB01+pJPAB01 strains, we used a murine peritoneal sepsis model in which 5.3 log 10 CFUs/mL of each strain was inoculated intraperitoneally in 5 mice from each group. Lungs and spleens showed lower mean bacterial concentrations in mice infected with JPAB01 strain than in those receiving the ATCC 17978 wt strain (lungs, 7. 10 CFUs/g for lungs and spleen, respectively). These data demonstrate that loss of OmpA affects the dissemination of A. baumannii in mice.
Patients and A. baumannii Isolates in Unicenter and Multicenter Cohorts
From the multicenter cohort, 30 PP and 37 CP were studied. Among the 30 PP, 10 A. baumannii isolates were obtained from BPP, and 20 from nonbacteremic patients (NBPP). In the NBPP, studied variables were found between CP and PP in each cohort, except for the ompA expression. qRT-PCR analysis showed that pneumonia producing strains significantly overexpress ompA with respect to colonizing strains with a ratio of 1.36 versus 0.91 (P = .03) in the multicenter cohort, and 1.76 versus 0.36 (P < .001) in the unicenter cohort (Table 1) . To corroborate these data, Western blot analysis showed that 4 isolates from PP randomly selected from unicenter and multicenter cohorts produced ≥2-fold higher OmpA than 4 isolates from CP (Supplementary Figure S1) , correlating with ompA expression analyzed by qRT-PCR (R 2 = 0.94) (Supplementary Figure S2 ). In the same way, the strains of BPP expressed more ompA than those from CP, with a ratio of 2.03 versus 0.91 (P = .004) for the multicenter and 2.37 versus 0.36 (P = .001) for the unicenter cohort ( Table 2 ). The demographic and clinical characteristics of CP and BPP did not differ significantly, except that in the unicenter cohort mortality rates were higher in BPP than in CP (80% vs 25%; P = .047; Table 2 ). In addition, to determine whether the occurrence of bacteremia is related to the overexpression of OmpA, we compared the expression of ompA in NBPP and BPP isolates; BPP isolates overexpress ompA nonsignificantly compared with the NBPP isolates, with a ratio of 2.03 versus 0.91 (P = .14) for the multicenter and 2.37 versus 1.43 (P = .06) for unicenter cohort (Table 3 ). The demographic and clinical characteristics of BPP and NBPP did not differ, except that female sex in the unicenter cohort was more frequent in BPP than in NBPP (P = .03; Table 3 ).
To explore whether the increase of patients sample size may show differences in mortality rates among the different groups of patients, we grouped both cohorts in the same group (n = 72 patients). We did not find any differences in mortality rates comparing CP with PP, NBPP, or BPP or comparing NBPP with BPP (Table 4) . Moreover, the analysis of ompA expression in the combined cohort showed higher ratios in strains from PP (1.44), NBPP (1.19), or BPP (2.37) than in those from CP (0.64) (P < .001, P = .009, and P < .001, respectively). Finally, compared with strains from NBPP, those from BPP expressed more ompA (2.37 vs 1.19; P = .04; Table 4 ).
OmpA Association With Pneumonia, Bacteremia, and Death
The multivariate analysis in both cohorts grouped together (n = 72; CP and PP) showed ompA expression as an independent risk factor for pneumonia and bacteremia (odds ratio Tables 5 and 6 ).
In addition, the multivariate analysis of risk factors associated with death in both cohorts grouped together (CP and PP) showed that ompA expression and McCabe score were independently associated with death (OR, 1.62 [95% CI, .98-2.69; P = .049] and 4.5 [1.29-15.7; P = .02], respectively). If bacteremia was included in the analysis, the McCabe score and mechanical ventilation were independently associated with death (OR, 4.48 [95% CI, 1.29-15.6; P = .02] and 3.99 [.94-16.91; P = .046], respectively), and the ompA expression showed a trend association, although nonsignificant, with death (OR, 1.59; .94-2.69; P = .09; Table 7 ). Furthermore, when only PP were analyzed, ompA expression was not associated with death (OR, 1.49; 95% CI, .8-2.79; P = .21; data not shown).
DISCUSSION
A. baumannii is an important cause of nosocomial infections in most countries, and many outbreaks have been described in the literature [30] . OmpA is considered a possible important virulence factor in A. baumannii. However, the level of OmpA production by A. baumannii in epidemiological studies is unknown. Demographic and clinical features of CP, PP, NBPP, and BPP among patients from both unicenter and multicenter cohorts were homogeneous. Mortality rates were higher among BPP compared with CP in the unicenter cohort. However, BPP did not present with more severe illness or require more invasive procedures. No clinical factors were associated with the development of pneumonia.
In the current study, ompA was expressed more in PP and NBPP isolates than in CP isolates, being independently associated with pneumonia. Previous reports suggested that OmpA of A. baumannii and Klebsiella pneumoniae plays an important role in the progression of the pneumonia in murine experimental models [29, 31] . In our study, we showed that deletion of the ompA gene in A. baumannii reduces bacterial dissemination between organs and development of secondary pneumonia in murine peritoneal sepsis model by A. baumannii. Previous data showed that OmpA was required for the swarming motility and persistence of A. baumannii in murine lungs and consequently for the development of pneumonia in pneumonia model caused by A. baumannii [29, 32, 33] . Interestingly, Méndez et al [34] demonstrated that ex vivo incubation of a highly invasive MDR A. baumannii clone (AbH12O-A2, which infected >300 patients in the 12 de Octubre Hospital in Madrid, Spain) with bronchoalveolar lavage fluid and macrophages to simulate conditions in the respiratory tract increased ompA expression more specifically among other proteins in presence of macrophages [34] , suggesting that OmpA is fundamental for pathogenesis and virulence of A. baumannii in the airways and may play an important role in the dissemination of A. baumannii between organs and bloodstream.
Expression of ompA was greater in BPP than in CP isolates and was independently associated with bacteremia. Overexpression of ompA was suggested to contribute to the adherence of enterohemorragic Escherichia coli to HeLa cells [35] . OmpA was required by E. coli to cross the blood-brain barrier and induce a high level of bacteremia [36, 37] . We know that other outer membrane proteins are associated with bacteremia. For example, OmpT, an outer membrane protease that might contribute to virulence of E. coli by inactivating host defense proteins and cleaving host cell-surface peptides [38] , was identified as the strongest virulence factor predictor of bacteremia in military veteran patients [39] . The protein P2, a porin of Haemophilus influenza, has been shown to be associated with the production of bacteremia in infant rats after intraperitoneal challenge [40] .
OmpA was independently associated with death when bacteremia was excluded from the multivariate analysis of both CP and PP. Several studies indicate a significant role of OmpA in deaths caused by gram-negative bacilli in experimental models of infection. In the current study, we demonstrated that deletion of the ompA gene rendered A. baumannii defective in causing death in a mouse model of infection by A. baumannii. Mutations in loops 1 and 2 of OmpA in E. coli and a knockout ompA gene in Enterobacter sakazakii showed substantially better survival than wt strains in newborn mice and rat meningitis caused by E. coli and E. sakazakii, respectively [41, 42] . It is noteworthy that the difference in ompA expression observed between A. baumannii isolates of unicenter cohort is clonally independent. Eight CP and 9 PP isolates from the same clone showed different levels of ompA expression; CP isolates had lower ompA expression than PP isolates, with a ratio of 0.4 versus 1.76 (P < .05).
Our study has several limitations. The first is the small sample size used. A larger sample would be welcomed to confirm our hypothesis and to obtain a threshold that can be used to predict the virulence of A. baumannii in daily clinical practice. Moreover, in the future, it is necessary to analyze ompA expression directly in clinical samples, such as tracheobronchial aspirate and blood samples, to avoid any experimental artifact that may be produced during bacterial growth in vitro. In addition, we have only been able to analyze the available data. For this reason, some risk factors related to A. baumannii infection, such as previous antibiotic therapy, as well as some mortality risk factors in PP, such as the Acute Physiology and Chronic Health Evaluation (APACHE) II score or appropriate initial antibiotic therapy, could not be included in the multivariate analysis. Finally, the significance of our present results would be substantially increased with an experimental model of infections showing the role of OmpA overexpression in the pathogenesis of A. baumannii; however, we already know that deletion of the ompA gene in A. baumannii reduces bacterial dissemination between organs and development of secondary pneumonia and pneumonia in murine peritoneal sepsis and pneumonia models, respectively.
Given our confirmation of our working hypothesis, we suggest that qRT-PCR monitoring of ompA expression could help in assessing new treatment regimens for A. baumannii infection, countering a poor prognosis or evolution of infection. The clinical implications of our findings suggest that compounds blocking OmpA might be a promising new treatment approach for infections caused by gram-negative bacilli, especially A. baumannii.
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